Evidence map›Paper›PMID 23708660›Full record

ArticleOncogene2014

Matrix metalloprotease 1a deficiency suppresses tumor growth and angiogenesis.

C J Foley, M Fanjul-Fernández, A Bohm, N Nguyen, A Agarwal, K Austin, G Koukos, L Covic, C López-Otín, A Kuliopulos

Open access · greenAbstract read
In one paragraph

Article in Oncogene, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Metalloproteases in gonad formation and ovulation.General and comparative endocrinology · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Fibroblasts in the Tumor Microenvironment: Shield or Spear?International journal of molecular sciences · 2018
    Review
  14. Article
  15. Article
  16. Article
  17. miR-526b targets 3' UTR of MMP1 mRNA.Experimental & molecular medicine · 2015
    Article
  18. Article
  19. Article
  20. Mmp1a and Mmp1b are not functional orthologs to human MMP1 in cigarette smoke induced lung disease.Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

C J Foley1] Molecular Oncology Research Institute, Division of Hematology-Oncology, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA [2] Program in Genetics at the Sackler School of Graduate Biomedical Sciences, Departments of Biochemistry and Medicine, Tufts University School of Medicine, Boston, MA, USA.
M Fanjul-FernándezDepartamento de Bioquímica y Biología Molecular, Facultad de Medicina, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain.
A BohmProgram in Genetics at the Sackler School of Graduate Biomedical Sciences, Departments of Biochemistry and Medicine, Tufts University School of Medicine, Boston, MA, USA.
N NguyenMolecular Oncology Research Institute, Division of Hematology-Oncology, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA.
A AgarwalMolecular Oncology Research Institute, Division of Hematology-Oncology, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA.
K Austin1] Molecular Oncology Research Institute, Division of Hematology-Oncology, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA [2] Program in Genetics at the Sackler School of Graduate Biomedical Sciences, Departments of Biochemistry and Medicine, Tufts University School of Medicine, Boston, MA, USA.
G Koukos1] Molecular Oncology Research Institute, Division of Hematology-Oncology, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA [2] Program in Genetics at the Sackler School of Graduate Biomedical Sciences, Departments of Biochemistry and Medicine, Tufts University School of Medicine, Boston, MA, USA.
L Covic1] Molecular Oncology Research Institute, Division of Hematology-Oncology, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA [2] Program in Genetics at the Sackler School of Graduate Biomedical Sciences, Departments of Biochemistry and Medicine, Tufts University School of Medicine, Boston, MA, USA.
C López-OtínDepartamento de Bioquímica y Biología Molecular, Facultad de Medicina, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain.
A Kuliopulos1] Molecular Oncology Research Institute, Division of Hematology-Oncology, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA [2] Program in Genetics at the Sackler School of Graduate Biomedical Sciences, Departments of Biochemistry and Medicine, Tufts University School of Medicine, Boston, MA, USA.
Molecular Oncology (United States) · USTufts University · USUniversidad de Oviedo · ES

Funding

THROMBIN RECEPTOR-G PROTEIN SIGNALING MECHANISMSR01HL064701 · NHLBI · TUFTS MEDICAL CENTER · PI KULIOPULOS, ATHAN · 2001 to 2011
$3.8M
Protease Activated Receptors in Cancer InvasionR01CA104406 · NCI · TUFTS MEDICAL CENTER · PI COVIC, LIDIJA · 2005 to 2009
$1.6M
Inter-Cellular Signaling of Invastion Receptors in the Tumor MicroenvironmentR01CA122992 · NCI · TUFTS MEDICAL CENTER · PI KULIOPULOS, ATHAN · 2007 to 2010
$1.2M
MMP1-PAR1 Signaling in Vascular Integrity During SepsisF30HL104835 · NHLBI · TUFTS UNIVERSITY BOSTON · PI FOLEY, CAITLIN J · 2010 to 2013
$165k
NCI NIH HHS CA104406NCI NIH HHS CA122992NCI NIH HHS R01 CA104406NCI NIH HHS R01 CA122992NHLBI NIH HHS F30 HL104835NHLBI NIH HHS F30-HL104835NHLBI NIH HHS HL64701NHLBI NIH HHS R01 HL064701
6 · The paper itself

Abstract

Matrix metalloprotease-1 (MMP1) is an important mediator of tumorigenesis, inflammation and tissue remodeling through its ability to degrade critical matrix components. Recent studies indicate that stromal-derived MMP1 may exert direct oncogenic activity by signaling through protease-activated receptor-1 (PAR1) in carcinoma cells; however, this has not been established in vivo. We generated an Mmp1a knockout mouse to ascertain whether stromal-derived Mmp1a affects tumor growth. Mmp1a-deficient mice are grossly normal and born in Mendelian ratios; however, deficiency of Mmp1a results in significantly decreased growth and angiogenesis of lung tumors. Coimplantation of lung cancer cells with wild-type Mmp1a(+/+) fibroblasts completely restored tumor growth in Mmp1a-deficient animals, highlighting the critical role of stromal-derived Mmp1a. Silencing of PAR1 expression in the lung carcinoma cells phenocopied stromal Mmp1a-deficiency, thus validating tumor-derived PAR1 as an Mmp1a target. Mmp1a secretion is controlled by the ability of its prodomain to facilitate autocleavage, whereas human MMP1 is efficiently secreted because of stable pro- and catalytic domain interactions. Taken together, these data demonstrate that stromal Mmp1a drives in vivo tumorigenesis and provide proof of concept that targeting the MMP1-PAR1 axis may afford effective treatments of lung cancer.

Indexed as

Amino Acid SequenceAnimalsCarcinogenesisCarcinoma, Lewis LungCell Line, TumorChlorocebus aethiopsCOS CellsEnzyme PrecursorsFemaleHEK293 CellsHumansLung NeoplasmsMaleMatrix Metalloproteinase 1MiceMice, Inbred C57BLEnzyme PrecursorsMatrix Metalloproteinase 1Mmp1a protein, mouseProtein Sorting Signals

Identifiers

PMID23708660
PMCPMC4221191
OpenAlexW2047987355

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.